CLDI (Calidi Biotherapeutics, Inc.) Stock Analysis - Politician Trades

Calidi Biotherapeutics, Inc. (CLDI) is a publicly traded Healthcare sector company. As of May 21, 2026, CLDI trades at $0.17 with a market cap of $2.79M and a P/E ratio of -0.03. CLDI moved -8.04% today. Year to date, CLDI is -85.53%; over the trailing twelve months it is -96.84%. Its 52-week range spans $0.16 to $46.68. Rallies surfaces CLDI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded CLDI stock?

Rallies tracks politician and congressional stock disclosures for CLDI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

CLDI Key Metrics

Key financial metrics for CLDI
MetricValue
Price$0.17
Market Cap$2.79M
P/E Ratio-0.03
EPS$-5.95
Dividend Yield0.00%
52-Week High$46.68
52-Week Low$0.16
Volume256.88K
Avg Volume0
Revenue (TTM)$0
Net Income$-20.06M
Gross Margin0.00%

Latest CLDI News

Recent CLDI Insider Trades

  • Camaisa Allan sold 850 (~$1.24K) on Dec 12, 2025.
  • Schoeneck James A bought 75.00K (~$150.00K) on Aug 21, 2025.
  • Poma Eric E bought 25.00K (~$50.00K) on Aug 21, 2025.

CLDI Analyst Consensus

CLDI analyst coverage data. Average price target: $0.00.

Common questions about CLDI

Which politicians traded CLDI stock?
Rallies tracks politician and congressional stock disclosures for CLDI, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in CLDI?
Yes. Rallies tracks politician and congressional stock disclosures for CLDI, including reported purchases, sales, dates, owners, and trade amounts when available.
Is CLDI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CLDI. It does not provide personalized investment advice.
CLDI

CLDI